Healthy volunteers to test liquid Diet's gut effects

NCT ID NCT07426003

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Aug 07, 2026 · Updated 2 times

Summary

This study will give 25 healthy adults a special liquid nutrition formula or a restricted diet of chicken, eggs, potatoes, bananas, and apples. Researchers will measure how fast food moves through the gut using a swallowed marker and X-rays. The goal is to understand how these diets affect digestion in people without gut disease.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Kate Farms Peptide 1.5 (a liquid nutrition formula) and a Crohn's disease exclusion diet (chicken, eggs, potatoes, bananas, apples)
What this could lead to
If successful, this study could help researchers understand how enteral nutrition works in the gut, which may guide future treatments for inflammatory bowel diseases.
What could go wrong
This is a small, early-stage study in healthy volunteers, not patients. It only measures digestion markers, not disease outcomes, so results may not apply to people with gut inflammation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 25 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2026

Expected to finish

May 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 70 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Must be able to read and understand English 2. Must be able to sign a consent form for the study Exclusion Criteria: 1. BMI \<20 or \>30 2. Unintentional weight loss of \>10% in the last 3-6 months 3. Kidney disease 4. Diagnosis of cirrhosis 5. Taking diuretics 6. Anemia - Hemoglobin \<lower limit of normal in men or \<10 g/dL in women. 7. Taking iron supplements within 2 weeks for Visit 2.1 8. Taking prebiotic or probiotic supplements or any supplement including a multivitamin within 2 weeks of Visit 2.1 9. Taking antibiotics less than 4 weeks prior to Visit 2.1 10. Diarrhea in the 2 weeks prior to Visit 2.1 11. Diabetes mellitus 12. Diagnosis of congestive heart failure 13. Diagnosis of inflammatory bowel disease or celiac disease 14. Bowel resection other than an appendectomy 15. Pregnancy or breastfeeding 16. Intolerance or allergy to nutritional formula, chicken, eggs, apples, banana, potatoes 17. Using protein supplements, including powder added to food or drinks within 2 weeks of Visit 2.1 18. Baseline bowel frequency less than every 2 days or greater than 3 times daily 19. Student or employee of any one of the investigators. 20. Anyone who cannot receive study payment (e.g. visa constraints). 21. Any condition that the investigator feels may limit the volunteer's ability to complete the study protocol.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Enteral nutrition's effect on the gut are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Penn Center for Advance Medicine, University of Pennsylvania

    RECRUITING

    Philadelphia, Pennsylvania, 19104, United States